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Heteromolecular compounds in binary systems of
amino acids with opposite and same chiralities†
Anton I. Isakov,a Heike Lorenz, *b
Andrey A. Zolotarev Jr a and Elena N. Kotelnikova a
A classification of discrete compounds in binary chiral systems of single and different substances (homo-
and heteromolecular compounds) is presented. It considers both chemical and crystallographic
characteristics of such compounds. Using amino acids as chiral model systems, features of crystal
structures of equimolar and non-equimolar heteromolecular compounds are reviewed. In this connection,
the concept of homo- and heteromolecular dimers in compounds formed by amino acids is introduced
and analyzed. As a result, a correlation between the molecular dimer type and the side chain structure
(linear or branched) and the conformation (extended or folded) of the relevant compounds' molecules is
derived. Two non-equimolar discrete heterocompounds discovered in the chiral systems L-valine–L-
isoleucine and L-valine–L-leucine are discussed using the concepts proposed. The previously studied first
system features a 2 : 1 (Val : Ile) compound. A newly investigated second system is found to form a 3 : 1 (Val :
Leu) compound, and its crystal structure is described and evaluated.
1. Introduction
Many organic substances are chiral molecules, which can
exist as levo and dextrorotatory optical antipodes. These
molecular entities being mirror images of each other and
non-superposable are called enantiomers.1 In their molecular
structures, enantiomers possess a chiral element, which in
most cases is a chiral center and less frequently, a chiral
plane or a chiral axis. Usually, the chiral center is a so-called
asymmetric carbon atom, i.e. a carbon atom interlinked by
“tetrahedral” bonds to four different substituents (ligands).
Chiral molecules may have various numbers of chiral centers
(n), with n defining the number of possible configurations of
the molecule (2n). In a symmetric environment, all the
physical and chemical properties of enantiomers are
identical, except for the direction of plane-polarized light
rotation.
Size and shape of molecules and geometry of
intermolecular hydrogen bonds are general factors
influencing the molecular packing in crystal structures of
organic substances.2,3 In the case of chiral substances, the
molecule configuration becomes the main additional factor
for molecular packing.
Enantiomers are widely used in pharmaceuticals, food
industries and electronics. For example, in 2004, nine out of
the ten most sold drugs contained chiral active ingredients.4
Furthermore, in the same year, among the 16 newly approved
synthetic drugs, 13 were chiral with all of them being single
enantiomers.5 However, products of non-stereoselective
industrial synthesis are mixtures of both enantiomers.
Therefore, the problem of applicability of chiral substances
(for example, for API's production) is closely connected to the
problem of resolution of enantiomeric mixtures. The most
profitable resolution methods are crystallization methods
that require the understanding of phase equilibria in a
system and plotting its phase diagram.6
The largest part of published information on chiral
systems refers to enantiomers of a single substance, while
reports on enantiomeric systems of different substances are
rather rare. Amino acids are suitable model compounds to
investigate binary chiral systems of the latter type. The great
diversity of amino acids and relatively simple structures of
their molecules made them already model compounds, for
example, for the determination of hydrogen bond lengths in
proteins and other biopolymers.7,8
The vast variety of proteins is a result of the combination
of twenty proteinogenic α-amino acids, with nineteen being
chiral compounds. Among them, seventeen molecules
contain only one asymmetric carbon atom and, consequently,
exist as two enantiomers. Molecules of the residual amino
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acids, threonine and isoleucine, contain two asymmetric
carbon atoms and thus, exist as four stereoisomers forming
two enantiomer and four diastereomer pairs, respectively.
Eight proteinogenic α-amino acids are essential amino
acids, which cannot be produced by the human body and,
therefore, must be consumed. The subjects of our study,
the aliphatic amino acids valine (C5H11NO2), leucine
(C6H13NO2), and isoleucine (C6H13NO2), belong to this
group.
In this present work, we (1) introduce a classification of
discrete compounds formed in chiral systems (section 2), (2)
discuss the chiral molecular packing in crystal structures of
amino acids and their equimolar heteromolecular compounds
(sections 3 and 4), and (3) present detailed studies of mainly two
levorotatory amino acid systems, L-valine–L-leucine and L-valine–
L-isoleucine, as examples of binary chiral systems forming
non-equimolar heteromolecular compounds (section 5).
2. Classification of discrete
compounds in binary systems of
chiral molecules
A first classification attempt for such compounds was
proposed by the present authors earlier.9 We considered the
classification necessary, since in the literature, there is plenty
of information available on various types of chiral compounds,
but, at the same time, the compounds are described using
“spontaneously arisen” terms which are not self-sufficient, i.e.
they do not reflect the proper place of a particular compound
in the general hierarchy of chiral substances.
The revised classification is shown as a flow diagram in
Fig. 1. We implemented significant changes, namely, the
proposed concepts for homo- and heteromolecular dimers
(see sections 4.1 and 4.2), and considered diastereomers to
be different substances, differing on molecular structures
and physical characteristics. However, the key change is an
improved order of basic chemical and crystallographic
classifying features that define the hierarchy of chiral
compounds.
The chemical composition of a particular compound
became the first classifying feature, and the molecular ratio
of the components constituting a compound as the second
classifying feature. Consequently, in Fig. 1, compounds
formed in binary chiral systems were first divided into two
main types: homomolecular and heteromolecular discrete
compounds. Afterwards, they were split into equimolar and
non-equimolar compounds, respectively.
In the case of homomolecular compounds
(homocompounds), the third classifying feature is based on
the molecular packings' character in the crystal structure.
Accordingly, equimolar homocompounds are divided into
compounds with symmetry related molecular components
(centrosymmetric and non-centrosymmetric ones) and
compounds with symmetrically independent molecular
components. Exemplary centrosymmetric and non-
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centrosymmetric equimolar homocompounds are two
polymorphs of malic acids' true racemate, RSI and RSII,
respectively.9 An exemplary homocompound containing
symmetrically independent molecules is DL-allylglycine.18
Non-equimolar homocompounds, in turn, can be divided
into compounds having ordered and disordered molecular
positions. An exemplary compound with ordered molecular
positions is the non-equimolar discrete compound S3R of
malic acid.9,19 To the present authors' knowledge, there is no
available information in the literature about any non-
equimolar homocompounds with disordered molecular
positions.
In the case of heteromolecular compounds
(heterocompounds), the third classifying feature is the
chirality of the molecular components. Accordingly,
equimolar heterocompounds are divided into compounds
composed of molecular components with different chiralities
and ones with the same chirality. The crystal structure of
heterocompounds of either type can consist of
homomolecular or heteromolecular dimers.
In other words, systems with components having different
chiralities can produce compounds containing
homomolecular dimers (e.g., L-valine–D-norvaline, see section
4.1) and compounds containing heteromolecular dimers (e.g.,
D-valine–L-leucine, see section 4.2). Heterocompounds with
homomolecular dimers are found not only among amino
acids but also among other chiral organic compounds.20–25
As well as systems of components having the same chirality
can form compounds containing heteromolecular dimers
(e.g., L-malic acid–L-tartaric acid26) and, possibly, those
consisting of homomolecular dimers (no examples have been
found yet in the published literature).
Similarly, non-equimolar heterocompounds are divided into
compounds composed of molecular components with the
same or different chiralities. The latter case is found in
heterocompounds formed in the (+)-2,4-dimethylglutaric
acid–(−)-dilactic acid and (−)-2,4-dimethylglutaric acid–(+)-2-
methylglutaric acid systems.14 In contrast, the molecular
components of non-equimolar heterocompounds found by
the present authors in the systems of L-valine–L-isoleucine9,27
and L-valine–L-leucine (see section 5) have the same chirality.
3. Crystal structure of amino acids
The publications7–9,16,27–35 that appeared in the last decades
made a considerable contribution to the concept of
molecular structures of amino acids.
For the description of the amino acids' crystal structure,
the terms “dimer” and “molecular layer”9,27,36–38 will be
used. The enantiomer L-valine is applied here as a
representative example of a typical aliphatic amino acid.
Fig. 2a shows the projection of the L-valine crystal structure
onto the ac plane. In the crystal structure, it is possible to
distinguish dimers consisting of two levorotatory valine
molecules interlinked with hydrogen bonds (Fig. 2b).
Pairing of molecules with formation of a dimer is typical
for hydrophobic amino acids.7 Each dimer is bonded to
neighbor dimers in the ab plane via hydrogen bonds. Thus,
the thickness of the formed molecular layer in the direction
of the c axis is equal to one dimer molecule (two valine
molecules)‡ (Fig. 2a). The layers are interlinked via the van
der Waals bonds.
4. Crystal structure of equimolar
heterocompounds of amino acids
In the literature, there are no data found on equimolar
heterocompounds of amino acids having the same chirality.
Therefore, this present article concentrates on compounds
with molecular components that possess different chiralities,
i.e. different signs of optical activity S :R′ = 1 : 1 (see Fig. 1). A
considerable contribution to the investigation of such
heterocompounds was made by C. H. Görbitz, B. Dalhus and
co-workers.7,16,28–32,41 They systematically studied equimolar
compounds composed of molecules of different amino acids
using SCXRD techniques. These compounds have been
Fig. 2 Projection of the L-valine crystal structure on the ac plane of the monoclinic cell (a) and its dimer molecule (b). Hereinafter, dotted lines are
the hydrogen bonds. Images are constructed in the program Mercury40 using the structural data CSD LVALIN01.33























































































CrystEngComm, 2020, 22, 986–997 | 989This journal is © The Royal Society of Chemistry 2020
mentioned under various names including “1:1
complexes”,16,29,31,32 “diastereomeric complexes”,30
“pseudoracemic complexes”,41 and “quasiracemates”.7,28 To
describe the interactions of different molecules in crystal
structures of these compounds, C. H. Görbitz7 used
designations LD–LD and L1–D1 in accordance with the
geometry of the hydrogen bonds formed. In the following,
the terms homo- and heteromolecular dimers are used to
describe the crystal structures of amino acid
heterocompounds.
4.1. Equimolar heterocompounds of amino acids with
homomolecular dimers
Heterocompounds of this type will be examined on the
example of an equimolar discrete compound formed in the
amino acids' system L-valine–D-norvaline.31 Fig. 3a and b show
the homomolecular dimer molecules of L-valine and D-
norvaline, respectively. Fig. 3c presents the projection onto
the ac plane of the crystal structure (S. G. C2) of the
equimolar discrete compound of L-valine and D-norvaline
molecules. In its crystal structure, it is possible to distinguish
molecular layers having a thickness of one dimer molecule.
The homomolecular dimers of valine and norvaline are
alternating within each layer. The molecular layers are
practically perpendicular to the c axis of the monoclinic cell.
Neighbor layers are shifted along the a axis with respect to
each other and, therefore, the translation along the c axis
includes two molecular layers. Consequently, the monoclinic
cell of the heterocompound doubled in size in comparison to
that of L-valine (see Fig. 2).
4.2. Equimolar heterocompounds of amino acids with
heteromolecular dimers
Heterocompounds of this type will be examined on the
example of an equimolar discrete compound formed in the
amino acids' system D-valine–L-leucine.31 Fig. 4a shows a
heteromolecular dimer molecule composed of D-valine and
L-leucine molecules. In Fig. 4b, the projection onto the bc
plane of the crystal structure (S. G. P21) of the equimolar
compound of D-valine and L-leucine molecules is presented.
In this crystal structure, it is also possible to distinguish the
molecular layers having a thickness of one dimer molecule. It
is very important to note that in this case, all the dimeric
molecules are identical. It can be seen that the neighbor
layers are rotated by 180° in the ab plane with respect to each
other (Fig. 4b). Consequently, in this case, the translation
along the c axis also includes two molecular layers.
4.3. Discussion
The concept of homo- and heteromolecular dimers is
considered in the classification of discrete compounds in
binary chiral systems (Fig. 1). This concept is also reflected in
Tables 1 and 2, created using the results obtained by C. H.
Görbitz, B. Dalhus and co-workers.7,16,28–32 It should be noted
that only the equimolar heterocompounds of amino acids
having components with different chiralities were studied.
Among them, we consider here only the compounds whose
crystal structures have been deciphered.
In Table 1, the L and D components of a heterocompound are
arranged in separate columns. The equimolar heterocompounds
of aliphatic α-amino acids with homo- and heteromolecular
dimers are listed in parts 1 and 2 of Table 1, respectively. Each
part comprises two categories, distinguished in accordance with
the structure of radical R or the structure of the side chain of the
corresponding α-amino acid (see Fig. 5 and 6). The side chain
can be branched or linear. For example, molecules of valine
(C5H11NO2), leucine (C6H13NO2), and isoleucine (C6H13NO2)
(Fig. 6a) have a branched side chain, while molecules of
norvaline (C5H11NO2), norleucine (C6H13NO2), and methionine
(C5H11NO2S) (Fig. 6b) possess a linear one.
In the heterocompounds with homomolecular dimers
(Table 1, part 1), category 1a includes two compounds,
wherein both molecular components are linear. Category 1b
comprises ten compounds with the L component being
branched and the D component linear. In the
heterocompounds with heteromolecular dimers (Table 1, part
2), category 2a includes five compounds, wherein both
constituents are branched. Category 2b comprises four
Fig. 3 Homomolecular dimers of L-valine (a) and D-norvaline (b) and projection on the ac plane of the crystal structure of the equimolar discrete
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compounds wherein the L component is branched, while the
D component is linear.
This method of examining the equimolar
heterocompounds of amino acids reveals a connection
between the type of molecular dimers (homo- or
heteromolecular) and the side chain structure of the
molecular components (branched or linear). As seen in
Table 1, all the heterocompounds composed of molecular
components with linear side chains belong to group 1, i.e.
have homomolecular dimers. In turn, all the
heterocompounds consisting of components with branched
side chains belong to group 2, i.e. feature heteromolecular
dimers.
More complex is the case when one of the
heterocompound components is characterized by a branched
molecule and the other by a linear molecule. Compounds of
such a type are present in both parts in Table 1. Affinity of a
particular compound toward part 1 or 2 likely depends on
the nature of the branched molecular component. It turned
out that if the branched component is valine, isoleucine, or
allo-isoleucine (part 1b, Table 1), then the heterocompound
has homomolecular dimers. In turn, if the branched
component is leucine (part 2b, Table 1), then the resulting
heterocompound has heteromolecular dimers.
A probable explanation is based on the following. There
are two conformations of molecules in the crystal structures
of valine, isoleucine, and allo-isoleucine (Table 2). Relative to
each other, one of the conformations can be considered as
“extended” (Fig. 7a) and the other one as “folded” (Fig. 7b).
The differences between the extended and folded
conformations are clearly seen from the comparison of the
corresponding torsion angles in Fig. 7.
In the case of the equimolar homocompounds (true
racemates LD, Fig. 1), molecules of valine, isoleucine, and
allo-isoleucine adopt the folded conformation. In contrast, in
the case of the equimolar heterocompounds
(“quasiracemates” LD′, Fig. 1), they have the extended
conformation. This is confirmed by the examples of four
Fig. 4 L-Leucine–D-valine dimer molecule (a) and projection on the bc plane of the crystal structure of the equimolar heterocompound in the D-
valine–L-leucine system (b). Images are constructed in the program Mercury40 using the structural data CSD BERPET.31
Table 1 Equimolar heterocompounds formed in the binary systems of
aliphatic L- and D-amino acids
1. Equimolar heterocompounds of amino acids with homomolecular
dimers






1 L-Norvaline D-Norleucine 16
2 L-Methionine D-Norleucine 16






1 L-Valine D-α-Aminobutyric acid 31
2 L-Valine D-Norvaline 31
3 L-Valine D-Methionine 31
4 L-Valine D-Norleucine 16
5 L-Isoleucine D-Alanine 29
6 L-Isoleucine D-Norleucine 29
7 L-Isoleucine D-Norvaline 29
8 L-Isoleucine D-Methionine 29
9 L-Isoleucine D-α-Aminobutyric acid 29
10 L-allo-Isoleucine D-Norleucine 16
2. Equimolar heterocompounds of amino acids with heteromolecular
dimers






1 L-Leucine D-Valine 31
2 L-Leucine D-allo-Isoleucine 7
3 L-Isoleucine D-allo-Isoleucine 30
4 L-Isoleucine D-Valine 29
5 L-Isoleucine D-Leucine 29






1 L-Leucine D-Norleucine 16
2 L-Leucine D-α-Aminobutyric acid 31
3 L-Leucine D-Norvaline 31
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heterocompounds containing valine, five heterocompounds
containing isoleucine, and one heterocompound comprising
allo-isoleucine (see Tables 1 and 2). Another situation occurs
in the case of leucine. All the molecules in the crystal
structure of L-leucine are identical and, consequently, there is
no need to attribute a conformation. It was found that all the
heterocompounds containing leucine and linear molecules of
other amino acids form heteromolecular dimers (see 2b in
Table 1).
Table 3 summarizes the equimolar heterocompounds with
the L component being the aromatic α-amino acid
phenylalanine (C9H11NO2) and the D component as an
aliphatic amino acid. Similar to Table 1, Table 3 consists of
two parts comprising heterocompounds with homo- and
heteromolecular dimers, respectively. The phenylalanine
molecule (component 1) is considered as branched, since it
contains a phenyl group. The molecules of the aliphatic
amino acids (component 2) are both branched and linear
molecules.
Heterocompounds with homomolecular dimers (Table 3,
part 1) are represented exclusively by compounds whose both
the components have branched molecules and one of the
components is aromatic, while the other one is aliphatic. It
should be noted that when both branched components are
aliphatic molecules (see 2a in Table 1), the resulting
heterocompound, in contrast, is composed of
heteromolecular dimers.
Heterocompounds with heteromolecular dimers (Table 3,
part 2) are represented solely by compounds whose one of
the components has a branched molecule (aromatic
component), while the other one has a linear molecule
(aliphatic component). Thus, as in the case of
heterocompounds composed of two aliphatic amino acids,
the configuration of the molecular side chain greatly affects
the structure of the equimolar heterocompounds containing
an aromatic phenylalanine molecule.
5. Crystal structure of non-equimolar
heterocompounds of amino acids
In the literature, we did not find examples of non-equimolar
heterocompounds of amino acids with different chiralities
where their crystal structure is known (see also Fig. 1).
Therefore, in the following we focus on compounds
composed of amino acids of the same chirality. One has
already been reported by the authors, while the other one is
new and its crystal structure will be presented and discussed
below.
5.1. Non-equimolar heterocompounds with molecules of the
same chirality
Table 4 comprises the two amino acid systems, namely L-
valine–L-isoleucine and L-valine–L-leucine, together with the
associated non-equimolar compounds found. In the first
one, a molecular component ratio of Val : Ile = 2 : 1§ was
determined and the compound was designated as V2I.
27
The related results, including the crystal structure of
compound V2I, limits of solid solutions in the system, and
thermal deformations of the system components and
compound V2I, are discussed in detail in the previous
studies.9,27,37 The newly discovered compound in the L-
valine–L-leucine system has a molecular ratio of Val : Leu =
3 : 1 and is denoted V3L.
5.2. Crystal structure of the non-equimolar heterocompound
V3L
Samples of mixtures containing various contents of valine
and leucine were prepared by isothermal crystallization. The
reactants used were LĲ+)-valine and LĲ+)-leucine of 99% purity,
Table 2 Conformations of the branched molecules of valine, isoleucine,

















Fig. 5 General formula of α-amino acids (R – radical or side chain).
Fig. 6 Structural formulae of certain aliphatic α-amino acids with
branched (a) and linear (b) side chains (colored in green).
§ Hereinafter, international abbreviations of the amino acid names are used: Val
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purchased from Alfa Aesar, Massachusetts, USA. Pre-weighted
mixtures of the reactants were put into a weighing bottle and
dissolved in distilled water at 25 °C under continuous stirring
with a glass rod. Water was added until complete dissolution
of the substance. Then, the bottle was loosely covered with a
cap and kept undisturbed for a period of at least three weeks
at 25 °C until the solvent was completely evaporated.
Precipitates were then analyzed by means of powder X-ray
diffraction (PXRD) techniques. Fifteen samples of the
prepared valine/leucine mixtures having a varying
composition were studied using a Rigaku MiniFlex II
diffractometer with the following settings: CuKα radiation, a
scan speed of 2° min−1, a step of 0.02°, and 2θ range = 3–40°.
The obtained PXRD data suggested the formation of the new
compound V3L having a molar ratio of Val : Leu = 3 : 1. As
seen in Fig. 8, the diffraction pattern of this compound
differs from those of the system components Val and Leu
and is not their combination. Accordingly, two two-phase
regions were observed in-between monophasic areas
corresponding to compounds V3L, Val and Leu. The PXRD
data showed that the major volume of the 75 mol% Val/25
mol% Leu sample belongs to phase V3L, and the diffraction
peaks of other phases are practically absent. The most well-
shaped crystal found in the sample was taken for structural
analysis.
Structural analysis of a V3L single crystal was performed
using a diffractometer Agilent Technologies SuperNova with
CuKα radiation and at a temperature of 100 K. The structure
has been solved by direct methods and refined by means of
the SHELX program incorporated in the OLEX2 program
package. The carbon- and nitrogen-bound H atoms were
placed in calculated positions and included in the
refinement in the ‘riding’ model approximation. The
Fig. 7 Extended (a) and folded (b) conformations of valine, isoleucine and allo-isoleucine molecules. Images are constructed in the program
Mercury40 using the structural data CSD LVALIN01, LISLEU02 and DAILEU01, respectively.
Table 3 Equimolar heterocompounds in the binary systems of L-
phenylalanine and various aliphatic D-amino acids
1. Equimolar heterocompounds with homomolecular dimers






1 L-Phenylalanine D-Leucine 32
2 L-Phenylalanine D-Isoleucine 32
3 L-Phenylalanine D-allo-Isoleucine 32
2. Equimolar heterocompounds with heteromolecular dimers






1 L-Phenylalanine D-Norvaline 32
2 L-Phenylalanine D-α-Aminobutyric acid 32
3 L-Phenylalanine D-Methionine 32
Table 4 Non-equimolar heterocompounds in the binary systems of






L-Valine–L-isoleucine9,27,37 V2I 2 : 1
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experimental conditions applied and crystal structure
parameters of the non-equimolar heterocompound V3L are
summarized in Table 5. Fig. 9 shows the projection of the
V3I compounds' crystal structure onto the ac plane of the
monoclinic cell (Fig. 9a) and the V3L dimer molecule
(Fig. 9b).
Heterocompound V3L contains the molecules of valine
and leucine in a ratio of 3 : 1. Two out of four molecular
positions in the unit cell (Z = 4) are independent. One of the
independent positions is occupied by a valine molecule (1
Val) (Fig. 9b, left part). The other independent position is
disordered, i.e. it is characterized by mixed occupation. It can
be occupied with equal probability by either a valine or
leucine molecule (1/2 Val + 1/2 Leu) (Fig. 9b, right part).
Therefore, the total number of valine molecules in the
compounds' unit cell is (1 + 1/2) × 2 = 3, while the total
number of leucine molecules is 1/2 × 2 = 1. Consequently,
the heterocompound has a general formula of V3L. Since one
of the independent positions has a mixed occupation in the
crystal structure, two kinds of dimers exist: homomolecular
Val–Val and heteromolecular Val–Leu ones. The dimers are
connected to each other via hydrogen bonds in the bc plane
and, therefore, form a layer with a thickness of one dimer
molecule. The layers, in turn, are interlinked via van der
Waals bonds (Fig. 9a).
Fig. 8 Diffractograms of L-Val (a) and L-Leu (b). Experimental (c) and
calculated (d) diffraction patterns of the compound V3L obtained by
means of powder and single crystal diffraction, respectively.



















Radiation CuKα (λ = 1.54184)
2θ range for data collection/° 6.8–139.962
Index ranges −11 ≤ h ≤ 11, −6 ≤ k ≤ 6,
−16 ≤ l ≤ 16
Reflections collected 5431
Independent reflections 2475 [Rint = 0.0515, Rsigma = 0.0500]
Data/restraints/parameters 2475/1/189
Goodness-of-fit on F2 1.025
Final R indices [I ≥ 2σ(I)] R1 = 0.0687, wR2 = 0.1864
Final R indices [all data] R1 = 0.0829, wR2 = 0.2039
Largest diff.
peak/hole / e Å−3
0.35/−0.26
Flack parameter 0.0(2)
Fig. 9 (a) Projection of the crystal structure of non-equimolar discrete heterocompound V3L on the ac plane of the monoclinic cell.
42 (b) Dimer
molecule of heterocompound V3L; occupation degree of the left position is 100% Val; occupancy of the right position is mixed: 50% Val and 50%
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5.3. Discussion
In Fig. 10, the projections of the crystal structures of Leu, Val
and Ile are opposed to those of the respective
heterocompounds V3L and V2I. In addition, Table 6 contains
the corresponding monoclinic cell parameters for the
mentioned compounds.
As shown, the crystal structure of compound V3L closely
resembles the structures of Leu, Val, and Ile enantiomers
(Fig. 10). In the four compounds, the monoclinic cell comprises
four molecules, and its asymmetric unit includes two
molecules. Linear parameters a, b, and c and volume V of the
monoclinic cells have close values as well. The angular
parameter β of heterocompound V3L is notably larger than
those of the Leu, Val, and Ile enantiomers (Fig. 10 and Table 6).
The molecular components of both non-equimolar
heterocompounds V3L and V2I have the same (L) chirality and
both have disordered molecular positions. Nevertheless, the
comprehensive analysis of the crystal structures of V3L and
V2I revealed substantial differences. First, in the case of
compound V3L, only a half of the molecular positions show
mixed occupation (Fig. 11a), while in compound V2I, all the
molecular positions exhibit mixed occupation (Fig. 11b).
Second, the monoclinic cell of V3L comprises four molecules,
while that of V2I includes eight molecules, i.e. it is doubled
in the direction of the longest axis of the cell.27
The molecular components' conformations of non-
equimolar heterocompounds V3L and V2I are discussed
below. For convenience, the extended conformation of
molecules is marked with superscript e (Vale and Ilee) and
the folded conformation with symbol f (Valf and Ilef). As it
was already mentioned, there are no conformations
attributed to Leu molecules.
Fig. 10 Projections of Leu, Val, Ile, V3L and V2I crystal structures on the corresponding planes of their monoclinic cells.
Table 6 Parameters of the monoclinic cells of the Ile, Val, and Leu enantiomers and non-equimolar compounds V3L and V2I produced in the L-Val–L-
Leu and L-Val–L-Ile systems, respectively
Compound S. G. a, Å b, Å c, Å β, deg. V, Å3 Ref.
L-Ile P21 9.75(2) 5.32(2) 14.12(2) 95.8(2) 723 43
L-Val P21 9.71(1) 5.27(2) 12.06(2) 90.8(2) 617.07 33
L-Leu P21 9.562(2) 5.301(1) 14.519(3) 94.20(2) 733.965 35
V3L P21 9.6267(7) 5.2704(2) 13.829(2) 109.94(1) 659.6 This work
V2I C2 25.7697Ĳ14) 5.2445(2) 9.6681(6) 97.215(5) 1296.29 27
Fig. 11 Occupancy of molecular positions in the dimers of non-
equimolar heterocompounds V3L (a) and V2I (b). Ellipsoids reflect the
20% and 50% probabilities in the case of V3L and V2I, correspondingly.
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As given above, heterocompound V3L is characterized by
one ordered and one disordered positions in the asymmetric
unit. A 50/50 statistically mixed population of the disordered
position implies that in every monoclinic cell, one dimer is
composed solely of Val molecules (homomolecular dimer)
and the other dimer is composed of both Val and Leu
molecules (heteromolecular dimer) (Fig. 11a). One of the
valine molecules in the homomolecular dimer has extended
conformation Vale, while the other molecule has folded
conformation Valf (dimer Vale–Valf). The valine molecule in
the heteromolecular dimer shows extended conformation
Vale (dimer Vale–Leu). It means that the ordered position
is occupied by valine molecules having the extended
conformation only, while the disordered position is
populated with valine molecules having the folded
conformation and leucine molecules (Table 7).
The monoclinic cell of heterocompound V2I has two
independent molecular positions and both are disordered,
i.e. characterized by mixed occupation. Molecules occupying
one of these independent positions have extended
conformation, while molecules present in the other
independent position have folded conformation.
Consequently, the crystal structure contains dimers of four
types, namely, homomolecular dimers Vale–Valf and Ilee–Ilef
and heteromolecular dimers Vale–Ilef and Valf–Ilee (Table 7).
Therefore, it can be concluded that the currently known
non-equimolar heterocompounds of amino acids can be
divided into two groups. V3L as the compound of the first
group contains two independent molecular positions and
only one of them is disordered, while V2I as the compound
belonging to the second group has all its molecular positions
disordered. It should be noted that in the L-isoleucine–L-
leucine system, the recently found compound I3L belongs,
apparently, to the first group. The results of its investigation
were presented at a conference45 and will be published later.
6. Summary
Peculiarities of the crystal chemistry of heterocompounds
formed by α-amino acids, i.e. compounds consisting of
enantiomers of two different α-amino acids, have been
reviewed and studied. The consideration is complicated by
the lack of a common approach for terminology and
allocation of compounds with chiral molecules in the
literature. This complication for multi-component crystals, in
general, was mentioned also, for example, by G. R. Desiraju
et al.46 To improve this situation, a classification of discrete
compounds formed in binary chiral systems either by a single
substance (homomolecular compounds) or by different
substances (heteromolecular compounds) is proposed. The
classification is based on both chemical and crystallographic
characteristics of the discrete compounds. The concept of
homo- and heteromolecular dimers is introduced based on
the analysis of published results for amino acid equimolar
heterocompounds. Heterocompounds composed of
homomolecular dimers are characterized by alternating the
dimer molecules of each substance, while those consisting of
heteromolecular dimers are characterized by the dimer
molecules of different substances. The correlation found
between the dimer type and the side chain structure (linear
or branched) and the conformation (extended or folded) of
the relevant heterocompounds' molecules is discussed.
Equimolar heterocompounds of amino acids having
different chiralities are known from the published literature.
Their crystallochemical characteristics were analyzed based
on the data available from the CSD and other sources. The
proposed concept of homo- and heteromolecular dimers
allowed the division of the known equimolar
heterocompounds into two groups: those with homo- and
those with heteromolecular dimers. It was found that the
molecules of the same substance have different
conformations in the homo- and heteromolecular dimers. In
the case of the equimolar homocompounds (true racemates),
the branched side chain molecules have a folded
conformation, while in the case of the equimolar
heterocompounds, they are characterized by an extended
conformation. Equimolar heterocompounds of amino acids
having the same chirality have not yet been found in the
published literature.
Non-equimolar heterocompounds are very rare. Only three
examples of the compounds of chiral substances have been
reported in the literature. Two compounds consist of
molecules having different chiralities and their crystal
structures are unknown.14 The third compound was
described by the present authors27 and is an example of a
non-equimolar heterocompound composed of the same
Table 7 Population of the molecular positions in discrete heterocompounds V3L and V2I and the types of dimers comprising the molecules of Val and
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chirality molecules. The crystal structure of this compound
V2I, formed in the system L-Val–L-Ile, is characterized by two
disordered molecular positions in the asymmetric unit of its
monoclinic cell (S. G. C2). A recently revealed further example
is compound V3L in the system L-Val–L-Leu. Its crystal
structure exhibits one ordered and one disordered molecular
positions in the asymmetric unit of its monoclinic cell
(S. G. P21), thus differing from the crystal structure of
heterocompound V2I. The crystal structures of V2I and
V3L were analyzed using the concepts of homo- and
heteromolecular dimers, side chain types (linear or branched)
and molecular conformations (extended or folded). Of course,
further assessment of the presented structural trends
requires more data. Thus, in view of the poor quantity of
known crystal structures of non-equimolar compounds, there
is an obvious need for continuation of their investigations.
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